KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 64 filers reported holding KALA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -43.8% | 39,058 | +237.3% | 0.00% | – |
| Q1 2022 | $16,000 | -65.2% | 11,580 | -69.3% | 0.00% | -100.0% |
| Q4 2021 | $46,000 | +411.1% | 37,781 | +981.9% | 0.00% | – |
| Q3 2021 | $9,000 | -81.6% | 3,492 | -62.4% | 0.00% | -100.0% |
| Q2 2021 | $49,000 | +96.0% | 9,291 | +149.9% | 0.00% | – |
| Q1 2021 | $25,000 | -74.7% | 3,718 | -74.6% | 0.00% | -100.0% |
| Q4 2020 | $99,000 | -67.5% | 14,636 | -64.0% | 0.00% | 0.0% |
| Q3 2020 | $305,000 | +464.8% | 40,681 | +689.2% | 0.00% | +50.0% |
| Q2 2020 | $54,000 | +20.0% | 5,155 | -57.5% | 0.00% | -50.0% |
| Q4 2019 | $45,000 | +181.2% | 12,131 | +196.0% | 0.00% | +300.0% |
| Q3 2019 | $16,000 | +300.0% | 4,098 | +692.6% | 0.00% | – |
| Q1 2019 | $4,000 | -71.4% | 517 | -80.9% | 0.00% | -100.0% |
| Q4 2018 | $14,000 | +250.0% | 2,705 | +836.0% | 0.00% | – |
| Q2 2018 | $4,000 | -81.0% | 289 | -74.4% | 0.00% | -100.0% |
| Q4 2017 | $21,000 | +40.0% | 1,131 | +78.1% | 0.00% | +200.0% |
| Q3 2017 | $15,000 | – | 635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
| RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
| Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
| Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
| Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
| Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
| Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
| Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |